Molecular basis of androgen receptor diseases

References

• Yong E L, Chua K L, Yang M, Roy A, Ratnam S S. Complete androgen insensitivity due to a splice-site mutation in the androgen receptor gene and genetic screening with single-stranded conformation polymorphism (SSCP). Fertil Steril 1994; 61: 856–62
   Google Scholar
• Gottlieb B, Lehvaslaiho H, Beitel L K, Lumbroso R, Pinsky L, Trifiro M. The androgen receptor gene mutations database. Nucleic Acids Res 1998; 26: 234–8
   PubMed Web of Science ®Google Scholar
• Yong E L, Tut T G, Ghadessy F J, Prins G, Ratnam S S. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain. Mol Cell Endocrinol 1998; 137: 41–50
   PubMedGoogle Scholar
• Ong Y C, Wong H B, Adaikan G, Yong E L. Directed pharmacological therapy of ambiguous genitalia due to an androgen receptor gene mutation. Lancet 1999; 354: 1444–5
   Google Scholar
• Tut T G, Ghadessy F, Trifiro M A, Pinsky L, Yong E L. Long polyglutamine tracts in the androgen receptor are associated with reduced transactivation, defective sperm production and male infertility. J Clin Endocrinol Metab 1997; 82: 3777–82
   PubMed Web of Science ®Google Scholar
• Ghadessy F J, Lim J, Abdullah A AR, Panet-Raymond V, Choo C K, Lumbroso R, et al. Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions. J Clin Invest 1999; 103: 1517–25
   Google Scholar
• Irvine R A, Yu M C, Ross R K, Coetzee G A. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1994; 54: 2861–4
   Google Scholar
• Rebbeck T R, Kantoff P W, Krithivas K, Neuhausen S, Blackwood M A, Godwin A K, et al. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet 1999; 64: 1371–7
   PubMed Web of Science ®Google Scholar
• Sawaya M E, Shalita A R. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J Cutan Med Surg 1998; 3: 9–15
   PubMedGoogle Scholar
• Vottero A, Stratakis C A, Ghizzoni L, Longui C A, Karl M, Chrousos G P. Androgen receptor-mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: skewing of X-chromosome inactivation. J Clin Endocrinol Metab 1999; 84: 1091–5
   PubMed Web of Science ®Google Scholar
• La Spada A R, Wilson E M, Lubahn D B, Harding A E, Fischbeck K H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991; 352: 77–9
   PubMed Web of Science ®Google Scholar
• Kawasaki T, Ushiyama T, Ueyama H, Inoue K, Mori K, Ohkubo I, et al. Polymorphic CAG repeats of the androgen receptor gene and rheumatoid arthritis. Ann Rheum Dis 1999; 58: 500–2
   PubMed Web of Science ®Google Scholar
• Quigley C A, De Bellis A, Marschke K B, El Awady M K, Wilson E M, French F S. Androgen receptor defects: historical, clinical and molecular perspectives. Endocr Rev 1995; 16: 271–321
   PubMed Web of Science ®Google Scholar
• McKenna N J, Lanz R B, O'Malley B W. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 1999; 20: 321–44
   PubMed Web of Science ®Google Scholar
• Lim J, Ghadessy F J, Yong E L. A novel splice site mutation in the androgen receptor gene results in exon skipping and a non-functional truncated protein. Mol Cell Endocrinol 1997; 131: 205–10
   Google Scholar
• Grino P B, Isidro-Gutierrez R F, Griffin J E, Wilson J D. Androgen resistance associated with a qualitative abnormality of the androgen receptor and responsive to high dose androgen therapy. J Clin Endocrinol Metab 1989; 68: 578–84
   PubMed Web of Science ®Google Scholar
• Hiort O, Huang Q, Sinnecker G H, Sadeghi-Nejad A, Kruse K, Wolfe H J, et al. Single strand conformation polymorphism analysis of androgen receptor gene mutations in patients with androgen insensitivity syndromes: application for diagnosis, genetic counseling, and therapy. J Clin Endocrinol Metab 1993; 77: 262–6
   Google Scholar
• Kazemi-Esfarjani P, Beitel L K, Trifiro M, Kaufhan M, Rennie P, Sheppard P, et al. Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes. Mol Endocrinol 1993; 7: 37–46
   Google Scholar
• Gottlieb B, Kaufhan M, Pinsky L, Leboeuf G, Sotos J F. Extracellular correction of the androgen-receptor transformation defect in two families with complete androgen resistance. J Steroid Biochem 1987; 28: 279–84
   Google Scholar
• Tanenbaum D M, Wang Y, Williams S P, Sigler P B. Crystallo-graphic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci USA 1998; 95: 5998–6003
   PubMed Web of Science ®Google Scholar
• Zukin B R, Santulli R, Awoniyo C A, Ewing L L. Maintenance of advanced spermatogenic cells in the adult rat testis: quantitative relationship to testosterone concentration within the testis. Endocrinology 1989; 124: 3043–9
   Google Scholar
• Kerr J B, Millar M, Maddocks S, Sharpe R M. Stage-dependent changes in spermatogenesis and Sertoli cells in relation to the onset of spermatogenic failure following withdrawal of testosterone. Anat Rec 1993; 235: 547–59
   PubMedGoogle Scholar
• Mitas M. Trinucleotide repeats associated with human disease. Nucleic Acids Res 1997; 25: 2245–54
   PubMed Web of Science ®Google Scholar
• Arbizu T, Santamaria J, Gomex J M, Quilez A, Serra J P. A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure. J Neurol Sci 1983; 59: 371–82
   PubMed Web of Science ®Google Scholar
• Amato A A, Prior T W, Barohn R J, Snyder P, Papp A, Mendell J R. Kennedy's disease: a clinicopathologic correlation with mutations in the androgen receptor gene. Neurology 1993; 43: 791–4
   PubMedGoogle Scholar
• Hardy D O, Scher H I, Bogenreider T, Sabbatini P, Zhang Z F, Nanus D M, et al. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab 1996; 81: 4400–5
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Stampfer M J, Krithivas K, Brown M, Dahl D, Brufsky A, et al. The CAG repeat within the androgen 34. receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1997; 94: 3320–3
   PubMed Web of Science ®Google Scholar
• Stanford J L, Just J J, Gibbs M, Wicklund K G, Neal C L, Blumenstein B A, et al. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 1997; 57: 1194–8
   PubMed Web of Science ®Google Scholar
• Dowsing A T, Yong E L, McLachlan R I, deKretser D, Trounson A. Linkage between male infertility and tri-nucleotide expansion in the androgen receptor gene. Lancet 1999; 354: 640–3
   PubMed Web of Science ®Google Scholar
• Chamberlain N L, Driver E D, Miesfeld R L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994; 122: 3181–6
   Google Scholar
• Hsiao P W, Lin D L, Nakao R, Chang C. The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated co-activator. J Biol Chem 1999; 274: 20229–34
   PubMed Web of Science ®Google Scholar
• Wang Q, Ghadessy F J, Yong E L. Analysis of the trans-activation domain of the androgen receptor in patients with defective spermatogenesis. Clin Genet 1998; 54: 185–92
   Google Scholar
• Yong E L, Liu P P, Sim C S, Vasan S S, Lim P HC, Ng S C (1998) The CAG repeat in the androgen receptor gene is associated with increased risk for either male infertility or prostate cancer (Abstract OR43–3). Proceedings of the 80th Annual Meeting of the Endocrine Society, New Orleans, LA, June, 24–271998. Endocrine Society, Bethesda, MD, 108
   Google Scholar
• Wang Q, Ghadessy F J, Trounson A, deKretser D, McLachlan R, Ng S C, et al. Azoospermia associated with a mutation in the ligand-binding domain of an androgen receptor displaying normal ligand binding, but defective trans-activation. J Clin Endocrinol Metab 1998; 83: 4303–9
   PubMedGoogle Scholar
• Yong E L, Ng S C, Roy A C, Yun G, Ratnam S S. Pregnancy after hormonal correction of severe spermatogenic defect due to mutation in androgen receptor gene. Lancet 1994; 344: 826–7
   Google Scholar
• Elo J P, Kvist L, Leinonen K, Isomaa V, Henttu P, Lukkarinen O, et al. Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol. J Clin Endocrinol Metab 1995; 80: 3494–500
   PubMed Web of Science ®Google Scholar
• Taplin M E, Bubley G J, Shuster T D, Frantz M E, Spooner A E, Ogata G K, et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 1995; 332: 1393–8
   PubMed Web of Science ®Google Scholar